REGINA LACEY: Open Payments
NPI 1326396193 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 10 payments from 5 companies in 2025. Trend: 2023 $1,077 · 2024 $750 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 2 | $282 |
| Neurocrine BioSciences, Inc. | 3 | $246 |
| Tris Pharma Inc | 3 | $183 |
| Astellas Pharma US Inc | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $122 |
Products named: FUROSCIX, Dyanavel XR, Veozah, Descovy, INGREZZA.
Industry payments across GA — which companies pay providers there.
